Govt defers proposed talks between chief negotiators on EU-BTIA
Updated: Aug 05, 2015 04:07:55pm
This decision has been taken as “The Government of India is disappointed and concerned by the action of EU in imposing legally binding ban on the sale of around 700 pharma products clinically tested by GVK Biosciences, Hyderabad’, Ministry of Commerce & Industry today said in a release.
The Government has engaged on the issue with various EU regulators over past 8 months.
Pharmaceutical industry is one of the flagship sectors of India which has developed its reputation through strong research and safety protocols over the years and therefore, Government of India will examine all options in this regard, it added.
It is pertinent to mention that most of these drugs are already in EU market for many years without any adverse pharmaco-vigilance report from any member state, the Ministry said. (KNN Bureau)





Loading...
